{"nct_id":"NCT02358031","title":"A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2015-03-19","start_date_type":"ACTUAL","primary_completion_date":"2019-02-25","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}